TY - JOUR
T1 - DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth
AU - Barra, Jonathan
AU - Crosbourne, Isaiah
AU - Roberge, Cassandra L.
AU - Bossardi-Ramos, Ramon
AU - Warren, Janine S.A.
AU - Matteson, Kailie
AU - Wang, Ling
AU - Jourd’heuil, Frances
AU - Borisov, Sergey M.
AU - Bresnahan, Erin
AU - Bravo-Cordero, Jose Javier
AU - Dmitriev, Ruslan I.
AU - Jourd’heuil, David
AU - Adam, Alejandro P.
AU - Lamar, John M.
AU - Corr, David T.
AU - Barroso, Margarida M.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/2/23
Y1 - 2024/2/23
N2 - Transient early endosome (EE)-mitochondria interactions can mediate mitochondrial iron translocation, but the associated mechanisms are still elusive. We showed that Divalent Metal Transporter 1 (DMT1) sustains mitochondrial iron translocation via EE-mitochondria interactions in triple-negative MDA-MB-231, but not in luminal A T47D breast cancer cells. DMT1 silencing increases labile iron pool (LIP) levels and activates PINK1/Parkin-dependent mitophagy in MDA-MB-231 cells. Mitochondrial bioenergetics and the iron-associated protein profile were altered by DMT1 silencing and rescued by DMT1 re-expression. Transcriptomic profiles upon DMT1 silencing are strikingly different between 2D and 3D culture conditions, suggesting that the environment context is crucial for the DMT1 knockout phenotype observed in MDA-MB-231 cells. Lastly, in vivo lung metastasis assay revealed that DMT1 silencing promoted the outgrowth of lung metastatic nodules in both human and murine models of triple-negative breast cancer cells. These findings reveal a DMT1‐dependent pathway connecting EE-mitochondria interactions to mitochondrial iron translocation and metastatic fitness of breast cancer cells. (Figure presented.)
AB - Transient early endosome (EE)-mitochondria interactions can mediate mitochondrial iron translocation, but the associated mechanisms are still elusive. We showed that Divalent Metal Transporter 1 (DMT1) sustains mitochondrial iron translocation via EE-mitochondria interactions in triple-negative MDA-MB-231, but not in luminal A T47D breast cancer cells. DMT1 silencing increases labile iron pool (LIP) levels and activates PINK1/Parkin-dependent mitophagy in MDA-MB-231 cells. Mitochondrial bioenergetics and the iron-associated protein profile were altered by DMT1 silencing and rescued by DMT1 re-expression. Transcriptomic profiles upon DMT1 silencing are strikingly different between 2D and 3D culture conditions, suggesting that the environment context is crucial for the DMT1 knockout phenotype observed in MDA-MB-231 cells. Lastly, in vivo lung metastasis assay revealed that DMT1 silencing promoted the outgrowth of lung metastatic nodules in both human and murine models of triple-negative breast cancer cells. These findings reveal a DMT1‐dependent pathway connecting EE-mitochondria interactions to mitochondrial iron translocation and metastatic fitness of breast cancer cells. (Figure presented.)
UR - http://www.scopus.com/inward/record.url?scp=85181479893&partnerID=8YFLogxK
U2 - 10.1038/s41388-023-02933-x
DO - 10.1038/s41388-023-02933-x
M3 - Article
AN - SCOPUS:85181479893
SN - 0950-9232
VL - 43
SP - 650
EP - 667
JO - Oncogene
JF - Oncogene
IS - 9
ER -